Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Men who start losing hair at age 30 may have a lower risk of prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

Finasteride effectively treats BPH and hair loss but may cause sexual side effects.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Dutasteride reduces DHT more effectively than finasteride.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Prostate size varies by ethnic group, age, residence, and blood glucose, but not by body measurements or fat.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Silver nanoparticles from Mitracarpus scaber protect the liver and reduce prostate enlargement.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Antioxidant-rich diets may reduce hair loss risk, while pro-inflammatory diets may increase it, especially in women.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Testosterone significantly affects urination differences between male and female mice.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Finasteride's effects on prostate cancer are not clear from this text.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

Higher urethral PSA levels after prostate removal surgery may be linked to more hair loss and higher PSA levels post-surgery.